Company intelligence / Profile preview

MYND Therapeutics

Vancouver, British Columbia, Canadamyndtx.com ↗
Ownership
Private
Employees
~20
Development stage
Commercial
01

Overview

MYND Therapeutics develops science-based, customer-centric digital therapies designed to prevent, treat, and manage chronic diseases such as obesity, diabetes, hypertension, depression, anxiety, and more. Their approach leverages innovative software experiences to deliver effective behavioral interventions with the goal of achieving outcomes comparable to drug therapies but with fewer side effects. The company aims for FDA approval of its core product as a prescribable therapy within an estimated timeframe of under two years from their last public update.[2][4]

Therapeutic areas
OncologyPsychiatryEndocrinologyCardiovascular
Modalities
Non-pharmacological therapy (digital therapy)Software-as-a-medical-device
Industry
Digital Health Medical Devices
02

Drug pipeline

1 asset

MYNDSET

Commercial
Indications
Obesity, Mental health
03

Partnerships

None publicly disclosed.

Beyond the preview

Go deeper on MYND Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYND Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call